Renaissance Technologies
AVNS

Renaissance Technologies’s Avanos Medical AVNS Stock Holding History

Renaissance Technologies’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-78,500
Closed -$907K – 3233
2025
Q3 		$907K Sell
78,500
-18,300
-19% -$214K ﹤0.01% 2533
2025
Q2 		$1.18M Buy
96,800
+79,900
+473% +$1M ﹤0.01% 2414
2025
Q1 		$242K Buy
+16,900
New +$264K ﹤0.01% 3004
2023
Q4 		– Sell
-59,868
Closed -$1.21M – 3727
2023
Q3 		$1.21M Buy
59,868
+41,668
+229% +$945K ﹤0.01% 2170
2023
Q2 		$465K Sell
18,200
-14,300
-44% -$377K ﹤0.01% 2910
2023
Q1 		$967K Buy
32,500
+10,900
+50% +$316K ﹤0.01% 2499
2022
Q4 		$584K Buy
+21,600
New +$528K ﹤0.01% 2865
2022
Q3 		– Sell
-8,800
Closed -$241K – 4013
2022
Q2 		$241K Sell
8,800
-3,000
-25% -$86.2K ﹤0.01% 3568
2022
Q1 		$395K Buy
+11,800
New +$380K ﹤0.01% 3332
2021
Q4 		– Sell
-132,300
Closed -$4.13M – 3888
2021
Q3 		$4.13M Buy
132,300
+44,500
+51% +$1.51M 0.01% 1590
2021
Q2 		$3.19M Buy
+87,800
New +$3.63M ﹤0.01% 1925
2020
Q3 		– Sell
-72,800
Closed -$2.14M – 3366
2020
Q2 		$2.14M Buy
+72,800
New +$2.11M ﹤0.01% 2151
2018
Q4 		– Sell
-140,700
Closed -$9.64M – 3371
2018
Q3 		$9.64M Sell
140,700
-177,100
-56% -$11.4M 0.01% 1387
2018
Q2 		$18.2M Buy
317,800
+85,600
+37% +$4.52M 0.02% 979
2018
Q1 		$10.7M Buy
232,200
+222,395
+2,268% +$10.6M 0.01% 1321
2017
Q4 		$453K Buy
+9,805
New +$451K ﹤0.01% 2909
2017
Q3 		– Sell
-46,300
Closed -$1.82M – 3196
2017
Q2 		$1.82M Buy
46,300
+27,221
+143% +$1.03M ﹤0.01% 2307
2017
Q1 		$727K Buy
+19,079
New +$743K ﹤0.01% 2652
2016
Q4 		– Sell
-93,300
Closed -$3.23M – 3239
2016
Q3 		$3.23M Buy
93,300
+68,200
+272% +$2.39M 0.01% 1899
2016
Q2 		$816K Buy
+25,100
New +$769K ﹤0.01% 2614
2015
Q3 		– Sell
-121,600
Closed -$4.92M – 3154
2015
Q2 		$4.92M Buy
+121,600
New +$5.46M 0.01% 1443

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's AVNS Position: Q4 2025 in Review

Renaissance Technologies sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 78,500 shares — an estimated $907K sold.

Renaissance Technologies first reported a position in AVNS in Q2 2015 and held it in 21 quarters. The position peaked at $18.2M in Q2 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Renaissance Technologies reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 78,500 Avanos Medical shares in Q4 2025, an estimated $907K.
  • Renaissance Technologies first reported a position in Avanos Medical in Q2 2015 and held it in 21 quarters.
  • Renaissance Technologies's Avanos Medical position peaked at $18.2M in Q2 2018.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.